Healix

Healthcare Resource Utilization in Inflammatory Bowel Disease Patients: A 2-Year Analysis

Authors:
Harry E. Sarles, MD, FACG – DHAT Research Institute, Richardson, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Sugar Land, TX
Thomas C. Hardin, PharmD – Healix Infusion Therapy, Sugar Land, TX
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound